论文部分内容阅读
高血脂及血液流变学的异常是心脑血管疾病发生及发展的高危因素。1998年1月～1999年1月我们以藻酸双脂钠作对照,观察了血脂康治疗高血脂及血液流变异常的疗效,现汇报如下。
Hyperlipemia and hemorheology abnormalities are risk factors for the occurrence and development of cardiovascular and cerebrovascular diseases. From January 1998 to January 1999, we used sodium alginate as a control to observe the therapeutic effect of Xuezhikang on hyperlipemia and abnormal blood rheology. The report is reported as follows.